Wegovy (Semaglutide) Stomach Paralysis & Serious Injury Claims

Wegovy® (semaglutide) is a GLP-1 receptor agonist approved by the FDA for chronic weight management. While it has gained widespread popularity for weight loss, mounting reports suggest that some patients have suffered severe and potentially permanent injuries after using the drug.

If you or a loved one experienced serious gastrointestinal complications, vision loss, or other severe side effects after taking Wegovy, you may be entitled to financial compensation.

The Michael Brady Lynch Firm is currently reviewing Wegovy injury claims nationwide.

What Is Wegovy?

Wegovy is a prescription injectable medication manufactured by Novo Nordisk and approved in 2021 for chronic weight management in adults with obesity or weight-related medical conditions. The medication works by mimicking the GLP-1 hormone, slowing gastric emptying, suppressing appetite, and helping regulate blood sugar levels. While these mechanisms can support meaningful weight loss, they also significantly affect the digestive system and may increase the risk of gastrointestinal complications in certain individuals.

Reported Wegovy Injuries

Although many patients tolerate Wegovy, others have reported serious adverse events. Alleged complications include gastroparesis (stomach paralysis), intestinal blockage, pancreatitis, gallbladder disease, and sudden vision impairment such as Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). Symptoms may involve chronic nausea and vomiting, severe abdominal pain, malnutrition, emergency hospitalizations, or, in some cases, persistent effects even after discontinuing the medication. The severity and duration of these complications can vary depending on individual health factors and medical history.

Who May Qualify?

You may qualify for a Wegovy lawsuit if:

  • You were prescribed Wegovy for weight loss
  • You developed gastroparesis, bowel obstruction, or severe digestive complications
  • You required hospitalization or surgery
  • You suffered vision loss or pancreatic injury
  • A loved one died due to complications after taking Wegovy

Each case is evaluated individually based on medical documentation and injury severity.

Eligibility for Legal Action

Individuals may be eligible to pursue a claim if they were prescribed Wegovy for weight loss and later experienced serious medical complications. Qualifying circumstances may include the development of gastroparesis, bowel obstruction, severe digestive injuries, pancreatic damage, or sudden vision loss. Claims may also arise when hospitalization, surgery, or long-term medical treatment became necessary, or when a family member suffered fatal complications allegedly linked to the medication. Each potential case is carefully reviewed based on medical records, diagnosis, and the overall impact of the injury.

Potential Financial Recovery

When a claim is successful, compensation is intended to address both economic and non-economic losses resulting from the injury. Recoverable damages may include reimbursement for past and future medical expenses, lost wages, diminished earning capacity, and ongoing treatment costs. In addition, individuals may seek compensation for pain and suffering, emotional distress, and other long-term consequences. In cases involving a fatal outcome, wrongful death damages may also be available to surviving family members, depending on the applicable law.

Speak With a Wegovy Injury Attorney

If you believe Wegovy caused serious harm, you should seek legal guidance promptly. There are strict time limits for filing pharmaceutical injury claims.

The Michael Brady Lynch Firm is currently accepting Wegovy cases nationwide.

Call toll-free: 877-513-9517
Free consultation. No obligation.

Get Trusted Legal Insights

Join our mailing list to receive helpful legal resources, firm updates, and important announcements. We’re here to keep you informed every step of the way.

Newsletter


Book a Free Consultation